Verrica Pharmaceuticals I... (VRCA)
NASDAQ: VRCA
· Real-Time Price · USD
6.18
0.03 (0.49%)
At close: Aug 15, 2025, 9:59 AM
Verrica Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 14.7M | 7.18M | 7.57M | 9.21M | 13.91M | 8.91M | 5.12M | 3.2M | 8.61M | 8.64M | 9.03M | -3.04M | -11.36M | -11.57M | n/a | 12M | 12M | 12M |
Cost of Revenue | 1.82M | 2.02M | 2.74M | 2.5M | 2.21M | 1.8M | 729.5K | 411K | 3.21M | 3.24M | 3.33M | 3.47M | 632K | 563K | 405K | 205K | 94K | n/a |
Gross Profit | 12.88M | 5.15M | 4.83M | 6.71M | 11.7M | 7.11M | 4.39M | 2.79M | 5.39M | 5.4M | 5.7M | -6.5M | -11.99M | -12.13M | -405K | 11.79M | 11.91M | 12M |
Operating Income | -38.73M | -55.45M | -65.92M | -75.11M | -78.32M | -74.73M | -63.22M | -48.84M | -23.47M | -20.98M | -21.3M | -23.55M | -36.77M | -38.38M | -30.91M | -34.47M | -32.34M | -30.24M |
Interest Income | 991K | 1.16M | 1.42M | 2M | 2.6M | 2.84M | 2.74M | 2.23M | 1.56M | 955K | 477K | 217K | 100K | 113K | 123K | 144K | 182K | 275K |
Pretax Income | -48.6M | -65.99M | -76.58M | -84.99M | -86.93M | -80.74M | -67M | -48.31M | -23.43M | -22.61M | -24.49M | -28.09M | -41.01M | -42.61M | -35.08M | -38.52M | -36.17M | -33.81M |
Net Income | -48.6M | -65.99M | -76.58M | -84.99M | -86.93M | -80.74M | -67M | -48.03M | -23.15M | -23.37M | -26.31M | -30.2M | -43.11M | -43.67M | -35.08M | -38.52M | -36.17M | -33.81M |
Selling & General & Admin | 43.66M | 51.33M | 58.82M | 65.94M | 69.91M | 59.33M | 47.3M | 33.5M | 17.37M | 16.61M | 17.41M | 19.33M | 23.41M | 25.52M | 26.98M | 31.63M | 28.27M | 26.1M |
Research & Development | 7.7M | 9.18M | 11.84M | 15.99M | 20.1M | 22.5M | 20.29M | 18M | 14.44M | 12.88M | 12.86M | 13.19M | 14.01M | 13.29M | 15.93M | 14.84M | 16.07M | 16.14M |
Other Expenses | 252K | 98K | 84K | -108.5K | 16.5K | 16.5K | 16.5K | 119K | -1K | -2K | -2K | 4K | -1K | n/a | n/a | -1K | -1K | -1K |
Operating Expenses | 51.62M | 60.6M | 70.75M | 81.82M | 90.02M | 81.84M | 67.62M | 51.63M | 31.81M | 29.48M | 30.27M | 32.52M | 37.41M | 38.81M | 42.91M | 46.47M | 44.34M | 42.24M |
Interest Expense | 9.06M | 9.3M | 9.41M | 9.37M | 8.65M | 6.28M | 3.96M | 1.66M | 81K | 1.15M | 2.23M | 3.33M | 4.34M | 4.35M | 4.29M | 4.19M | 4.01M | 3.84M |
Selling & Marketing Expenses | 5.1M | 6.2M | 7.4M | 3.7M | 2.6M | 1.5M | 3.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 53.44M | 62.63M | 73.48M | 86.86M | 94.77M | 86.18M | 70.88M | 52.04M | 32.08M | 29.61M | 30.33M | 32.52M | 37.41M | 38.81M | 42.91M | 46.47M | 44.34M | 42.24M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -281K | -281K | 766K | 1.83M | 2.11M | 2.14M | 1.12M | 64K | 64K | 97K | 64K |
Shares Outstanding (Basic) | 9.49M | 9.48M | 6.73M | 4.68M | 4.65M | 4.65M | 4.63M | 4.61M | 4.59M | 4.3M | 4.11M | 4.03M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.56M |
Shares Outstanding (Diluted) | 9.49M | 9.48M | 6.73M | 4.68M | 4.65M | 4.65M | 4.63M | 4.61M | 4.59M | 4.3M | 4.11M | 4.47M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.56M |
EPS (Basic) | -8.3 | -12.02 | -15.36 | -18.26 | -18.76 | -17.45 | -14.61 | -10.75 | -5.35 | -6.65 | -8.2 | -10.22 | -14.9 | -15.49 | -12.77 | -14.49 | -14.02 | -13.51 |
EPS (Diluted) | -8.3 | -12.02 | -15.36 | -18.26 | -18.76 | -17.45 | -14.61 | -10.75 | -5.35 | -6.65 | -8.2 | -10.22 | -14.9 | -15.49 | -12.77 | -14.49 | -14.02 | -13.51 |
EBITDA | -39.34M | -56.36M | -65.9M | -74.39M | -77.18M | -73.48M | -62.2M | -45.84M | -22.54M | -20.7M | -21.54M | -24.05M | -36.04M | -37.7M | -30.31M | -34.06M | -31.98M | -29.82M |
EBIT | -39.54M | -56.69M | -67.17M | -75.62M | -78.28M | -74.46M | -63.03M | -46.66M | -22.06M | -20.18M | -20.97M | -23.48M | -36.67M | -38.27M | -30.79M | -34.33M | -32.16M | -29.97M |
Depreciation & Amortization | 1M | 1.14M | 1.27M | 1.23M | 1.1M | 974K | 836K | 820K | 737K | 693K | 649K | 648K | 632K | 563K | 472K | 470K | 364K | 282K |